83 related articles for article (PubMed ID: 20030060)
1. [Construction and characterization of an attenuate strain apxIC-/P36+ of Actinobacillus pleuropneumoniae serovar 10].
Zou H; Chen Y; Liu X; He Q; Chen P; Zhou R; Ma F; Wang Y
Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1209-16. PubMed ID: 20030060
[TBL] [Abstract][Full Text] [Related]
2. [Construction and characteristics of a recombinant strain apx II C- /apx I A+ of Actinobacillus pleuropneumoniae serotype 7].
Liu JL; Bei WC; Lin LW; Xu YD; Chen HC
Wei Sheng Wu Xue Bao; 2007 Dec; 47(6):973-7. PubMed ID: 18271248
[TBL] [Abstract][Full Text] [Related]
3. [Construction and immunogenicity of an attenuated mutant of Actinobacillus pleuropneumoniae by insertional inactivation of apxIC].
Xu FZ; Shi AH; Chen XL; Yang B; Wang JL
Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):923-7. PubMed ID: 18062275
[TBL] [Abstract][Full Text] [Related]
4. Construction and immunogenicity of a ∆apxIC/ompP2 mutant of Actinobacillus pleuropneumoniae and Haemophilus parasuis.
Liu Q; Gong Y; Cao Y; Wen X; Huang X; Yan Q; Huang Y; Cao S
Onderstepoort J Vet Res; 2013 Mar; 80(1):519. PubMed ID: 23718128
[TBL] [Abstract][Full Text] [Related]
5. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1.
Lin L; Bei W; Sha Y; Liu J; Guo Y; Liu W; Tu S; He Q; Chen H
FEMS Microbiol Lett; 2007 Sep; 274(1):55-62. PubMed ID: 17608699
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker.
Bei W; He Q; Yan L; Fang L; Tan Y; Xiao S; Zhou R; Jin M; Guo A; Lv J; Huang H; Chen H
FEMS Microbiol Lett; 2005 Feb; 243(1):21-7. PubMed ID: 15667996
[TBL] [Abstract][Full Text] [Related]
7. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.
Liu J; Chen X; Lin L; Tan C; Chen Y; Guo Y; Jin M; Guo A; Bei W; Chen H
Vaccine; 2007 Nov; 25(44):7696-705. PubMed ID: 17767980
[TBL] [Abstract][Full Text] [Related]
8. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
[TBL] [Abstract][Full Text] [Related]
10. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
Liu J; Chen Y; Hu L; Bei W; Chen H
Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
[TBL] [Abstract][Full Text] [Related]
11. Generation, safety and immunogenicity of an Actinobacillus pleuropneumoniae quintuple deletion mutant SLW07 (ΔapxICΔapxIICΔorf1ΔcpxARΔarcA).
Yuan F; Liu J; You W; Bei W; Wang C; Zhao J; Tian Y; Liu S
Vaccine; 2018 Mar; 36(14):1830-1836. PubMed ID: 29486946
[TBL] [Abstract][Full Text] [Related]
12. Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.
Tonpitak W; Baltes N; Hennig-Pauka I; Gerlach GF
Infect Immun; 2002 Dec; 70(12):7120-5. PubMed ID: 12438394
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
[TBL] [Abstract][Full Text] [Related]
14. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.
Maas A; Jacobsen ID; Meens J; Gerlach GF
Infect Immun; 2006 Jul; 74(7):4124-32. PubMed ID: 16790786
[TBL] [Abstract][Full Text] [Related]
15. The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.
Fu S; Ou J; Zhang M; Xu J; Liu H; Liu J; Yuan F; Chen H; Bei W
Clin Vaccine Immunol; 2013 Feb; 20(2):134-9. PubMed ID: 23220998
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D
Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740
[TBL] [Abstract][Full Text] [Related]
17. [Cloning and expression of hemolytic-toxin from Actinobacillus pleuropneumoniae and the immunoprotection in mice].
Du A; Diao Y; Zhang W; Zhang R; Zang D; Liu F
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):342-8. PubMed ID: 18479061
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge.
Lu YC; Li MC; Chen YM; Chu CY; Lin SF; Yang WJ
Vaccine; 2011 Oct; 29(44):7740-6. PubMed ID: 21835218
[TBL] [Abstract][Full Text] [Related]
19. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
[TBL] [Abstract][Full Text] [Related]
20. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine.
Fuller TE; Thacker BJ; Duran CO; Mulks MH
Vaccine; 2000 Jun; 18(25):2867-77. PubMed ID: 10812230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]